"I strongly recommend if one is in the business of the provision of health care, then one should become comfortable in the area of asking questions"
I enjoyed the update in the article on the rise of congenital syphilis. I have been giving prenatal care since the late 1980s and have always screened initially then again at 35-36 weeks. We did not see patients in the hospital, but when they returned to us for their postpartum visit, they would be tested again.
It astounds me to hear that some of the reasons for not rescreening may be that “providers are hesitant to ask uncomfortable questions about sexual histories” or that “providers assume a treated patient will remain infection-free and do not retest”...or for that matter...that someone that has been treated is not rescreened because they are “not high risk??” I would think if they had syphilis and were treated...they would be high risk??? Common sense needed here, perhaps?
As healthcare providers, we are trained in this area - sexual practice assessment - and with experience comes comfort. So I strongly recommend if one is in the business of the provision of health care, then one should become comfortable in the area of asking questions - any questions - and getting answers, whether pleasant or not, to enable provision of the best health care possible. NOT asking is close to negligence, in my mind anyway.
Thank you very much for the simple reminders of how important it is to screen, rescreen and then hopefully at delivery...rescreen again.
Veronica L. Howard-Burch, PhD, MSN, RNCWomen’s Health Nurse Practitioner-BC
Fort Stockton, Texas
I could not agree more – these are the real-world limitations we have to deal with from a public health perspective. Thank you for your comments.
Dr. Lockwood
Unraveling preeclampsia: Insights into heterogeneity and intravascular inflammation
April 22nd 2024A recent study delved into the intricate clusters of term preeclampsia, shedding light on its diverse manifestations and the pivotal role of intravascular inflammation, paving the way for improved classification and management strategies.
Read More
Personalized opioid protocol for cesarean deliveries: Reduced prescriptions reported
April 19th 2024A recent suggests that implementing a personalized opioid prescription protocol significantly reduces total morphine milligram equivalents and the number of opioid tablets prescribed at discharge following cesarean delivery.
Read More
Long-term mortality risks for women with adverse pregnancy outcomes
April 19th 2024A recent study revealed that women who experience major adverse pregnancy outcomes face heightened long-term mortality risks, shedding light on the need for comprehensive understanding and preventative measures in women's health.
Read More